3 terminated, 2 unknown, 1 active not recruiting, 1 completed. 7 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 3, Unknown 2, Active not recruiting 1, Completed 1 |
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
Follow Deafness, Autosomal Recessive 39: new trials by email Literature Review of Deafness, Autosomal Recessive 39 trials Research Report on Deafness, Autosomal Recessive 39
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial) ATH-1017, Placebo - Parkinson Disease Dementia, Dementia With Lewy Bodies | Phase 2 | Terminated | LeonaBio | 28 | 2022-01-20 | 2025-03-04 |
| Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE) Tepotinib, Cetuximab - Colorectal Neoplasms | Phase 2 | Terminated | EMD Serono Research & Development Institute, Inc. | 3 | 2021-01-28 | 2022-12-22 |
| A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer REGN5093 - NSCLC | Phase 1 / Phase 2 | Active not recruiting | Regeneron Pharmaceuticals | 95 | 2020-01-07 | 2026-09-16 |
| Phase I/II Study of KP-100IT in Acute Spinal Cord Injury KP-100IT, Placebo - Spinal Cord Injuries | Phase 1 / Phase 2 | Completed | Kringle Pharma, Inc. | 45 | 2014-06-30 | 2019-06-05 |
| Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease Ad-HGF - Ischemic Heart Disease | Phase 1 / Phase 2 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 40 | 2012-11-01 | 2013-08-20 |
| Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack BB3, Normal saline - Myocardial Infarction | Phase 2 | Terminated | Angion Biomedica Corp | 5 | 2012-07-01 | 2014-11-21 |
| Study on Delayed Graft Function Using Paired Kidneys BB3, Normal Saline - Delayed Graft Function | Phase 2 | Unknown | Angion Biomedica Corp | 12 | 2011-08-01 | 2016-02-22 |
Adenoviridae Infections (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Delayed Graft Function (1) · Dementia (1) · Lewy Body Disease (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Neoplasm Metastasis (1) · ST Elevation Myocardial Infarction (1) · Spinal Cord Injuries (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Heart Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Nervous System Diseases (2) · Vascular Diseases (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · DNA Virus Infections (1)
Saline Solution (2) · Cetuximab (1) · Hepatocyte Growth Factor (1) · tepotinib (1)
Angion Biomedica Corp (2) · EMD Serono Research & Development Institute, Inc. (1) · Kringle Pharma, Inc. (1) · LeonaBio (1) · Regeneron Pharmaceuticals (1) · The First Affiliated Hospital with Nanjing Medical University (1)
United States (4) · France (2) · Spain (2) · United Kingdom (2) · Belgium (1) · China (1) · Czechia (1) · Italy (1) · Japan (1) · Netherlands (1) · Russia (1) · South Korea (1)
Weizhong Cai (1) · Zhijian Yang, PhD. (1)
2019 (1), 2023 (1), R44DK078455 (1), R44HL091699 (1)